GLP-1 Drugs Are Reshaping What Nutrition Science Needs to Answer Sunday's sessions addressed a clinical challenge that will define nutritional science for the next decade: how to manage the nutritional needs of millions of patients on GLP-1 receptor agonists drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) that suppress appetite so effectively they create real risk of protein and micronutrient deficiency, as covered in prior reporting on the ADA's 2026 scientific sessions
In one embodiment the enhanced viscosity auris-acceptable formulation described herein is not a liquid at room temperature
Sergey Terushkin, MD, FACS, now offers telehealth consultations for patients throughout the United States, making it easier than ever to access this breakthrough treatment without leaving your home
Other preliminary data suggest oral theanine along with cystine may reduce neuropathy in patients receiving oxaliplatin (33) and esophagitis in those undergoing chemoradiotherapy (35)
It isnt designed for people taking Mounjaro and wont help you lose weight like Mounjaro
Binge-eating disorder is a complex, she said, and the most effective ways of dealing with it are relearning behaviors, regulating emotions, and identifying triggers which are done through therapy, not by taking pills